Shanghai Fosun Pharmaceutical Group Co Ltd (600196)

Currency in CNY
27.79
+0.22(+0.80%)
Delayed Data·
600196 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
27.4927.84
52 wk Range
22.8833.10
Key Statistics
Bid/Ask
27.78 / 27.79
Prev. Close
27.57
Open
27.72
Day's Range
27.49-27.84
52 wk Range
22.88-33.1
Volume
10.91M
Average Volume (3m)
17.46M
1-Year Change
16.7157%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600196 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
38.76
Upside
+39.46%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Shanghai Fosun Pharmaceutical Group Co Ltd Company Profile

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory health and professional medical products; oncology, neuroscience and other specialty fields; and solutions for infections, tumors, the central nervous system, and chronic diseases. In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and special commodities; specialized medical disciplines; and insurance services. Further, it is involved in the import and export of medical equipment and the provision of related and other consulting services and investment management. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Employees
40557
Market
China

Compare 600196 to Peers and Sector

Metrics to compare
600196
Peers
Sector
Relationship
P/E Ratio
20.7x17.9x−0.6x
PEG Ratio
0.36−0.600.00
Price/Book
1.4x2.0x2.6x
Price / LTM Sales
1.7x2.5x3.4x
Upside (Analyst Target)
44.4%21.9%41.8%
Fair Value Upside
Unlock22.0%4.8%Unlock

Analyst Ratings

7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 38.76
(+39.46% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Hold37.63+35.55%29.03MaintainOct 31, 2025
Goldman Sachs
Hold29.03+4.57%25.39MaintainAug 28, 2025
HSBC
Hold25.30-8.86%23.00MaintainJun 10, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.24%
Dividend Yield
1.16%
Industry Median 1.45%
Annualized payout
0.32
Paid unevenly
5-Years Growth
-3.88%
Growth Streak

Earnings

Latest Release
Oct 28, 2025
EPS / Forecast
0.31 / 0.25
Revenue / Forecast
9.88B / 10.27B
EPS Revisions
Last 90 days

600196 Income Statement

People Also Watch

13.65
601600
+3.18%
29.96
600089
+4.94%
6.42
600028
+4.39%

FAQ

What Is the Shanghai Fosun Pharm (600196) Stock Price Today?

The Shanghai Fosun Pharm stock price today is 27.79

What Stock Exchange Does Shanghai Fosun Pharm Trade On?

Shanghai Fosun Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Shanghai Fosun Pharm?

The stock symbol for Shanghai Fosun Pharm is "600196."

Does Shanghai Fosun Pharm Pay Dividends? What’s The Current Dividend Yield?

The Shanghai Fosun Pharm dividend yield is 1.16%.

What Is the Shanghai Fosun Pharm Market Cap?

As of today, Shanghai Fosun Pharm market cap is 72.85B.

What Is Shanghai Fosun Pharm's Earnings Per Share (TTM)?

The Shanghai Fosun Pharm EPS (TTM) is 1.24.

When Is the Next Shanghai Fosun Pharm Earnings Date?

Shanghai Fosun Pharm will release its next earnings report on Mar 24, 2026.

From a Technical Analysis Perspective, Is 600196 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Shanghai Fosun Pharm Stock Split?

Shanghai Fosun Pharm has split 7 times.

How Many Employees Does Shanghai Fosun Pharm Have?

Shanghai Fosun Pharm has 40557 employees.

What is the current trading status of Shanghai Fosun Pharm (600196)?

As of Jan 25, 2026, Shanghai Fosun Pharm (600196) is trading at a price of 27.79, with a previous close of 27.57. The stock has fluctuated within a day range of 27.49 to 27.84, while its 52-week range spans from 22.88 to 33.10.

What Is Shanghai Fosun Pharm (600196) Price Target According to Analysts?

The average 12-month price target for Shanghai Fosun Pharm is CNY38.76, with a high estimate of CNY46 and a low estimate of CNY30. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +39.46% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.